Non-invasive Measures of Distal Lung Disease in Asthmatics

Phase 4

Completed

• Conditions: Asthma
• Interventions: Drug: Advair; Drug: QVAR; Drug: Servent Diskus

• Registration Number: NCT00250341
• Lead Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.

Brief Summary

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Detailed Description

The study consists of 3 phases. There are 7 study visits.

Study Timeline

• Study Start: 2005-09-30
• Study First Submitted: 2005-11-04
• Study First Submitted QC: 2005-11-07
• Study First Posted: 2005-11-08
• Primary Completion: 2007-09-30
• Study Completion: 2007-09-30
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-19
• Last Update Posted: 2021-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

• 18-65 years old
• Currently using SABA prn or a low-to-moderate persistent asthma

Exclusion Criteria

• Tobacco use within 1 year or >= 5 pack years

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
QVAR	Servent Diskus	-
Advair	Advair	-
QVAR	QVAR	-

Primary Outcome Measures

Name	Time	Method
High resolution Cat Scans

Trial Locations

Locations (1)

UCLA; 🇺🇸 Los Angeles, California, United States